3.42
-0.63(-15.56%)
Currency In USD
| Previous Close | 4.05 |
| Open | 3.64 |
| Day High | 3.7 |
| Day Low | 3.25 |
| 52-Week High | 4.67 |
| 52-Week Low | 0.85 |
| Volume | 11.52M |
| Average Volume | 3.23M |
| Market Cap | 155.85M |
| PE | -5.9 |
| EPS | -0.58 |
| Moving Average 50 Days | 3.11 |
| Moving Average 200 Days | 2.2 |
| Change | -0.63 |
If you invested $1000 in Microbot Medical Inc. (MBOT) 10 years ago, it would be worth $4.14 as of September 16, 2025 at a share price of $3.42. Whereas If you bought $1000 worth of Microbot Medical Inc. (MBOT) shares 5 years ago, it would be worth $464.04 as of September 16, 2025 at a share price of $3.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
GlobeNewswire Inc.
12 hours ago
$25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment optionsBRAINTREE, Mass., Sept. 15,
REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
GlobeNewswire Inc.
Sep 09, 2025 12:28 PM GMT
Live Presentation to be Webcast Today at 9am ETHINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, today announced that Harel Ga
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
GlobeNewswire Inc.
Sep 08, 2025 12:28 PM GMT
LIBERTY Endovascular Robotic System * Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025 The Company’s Ini